Acupoint TENS vs Resistance Training for Iron Deficiency Anemia (NCT07605676) | Clinical Trial Compass
RecruitingPhase 4
Acupoint TENS vs Resistance Training for Iron Deficiency Anemia
Egypt60 participantsStarted 2026-01-15
Plain-language summary
The current study is designed to compare between the effect of transcutaneous electrical acupoint stimulation and resistance exercises on hemoglobin level in women with iron deficiency anemia.The design of this study will be a randomized controlled trial (RCT) pretest post-test assessment.Sixty women diagnosed with iron deficiency anemia will be recruited in this study from Kafrelshiekh University Hospital, Kafrelshiekh Governorate, Egypt. Their ages will be ranged from 20 to 30 years old, and they will be randomly divided into three equal (n= 20) groups. Change in hemoglobin concentration (g/dL) after the intervention period and changes in RBC count, MCV, MCH, RDW, serum ferritin, fatigue level, and functional exercise capacity after treatment will be measured.
Who can participate
Age range
20 Years – 30 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sixty women diagnosed with iron deficiency anemia within ≤6 months.
* Their hemoglobin concentrations ranging from 8.0 to 10.9 g/dL that classified as moderate anemia in accordance with the World Health Organization (WHO) criteria.
* The iron deficiency anemia resulted from the heavy monthly bleeding of menstrual cycle as reported by the women.
* Their age will be ranged from 20 and 30 years old.
* Their BMI will be ranged from 18.5 to 24.9 kg/m².
* They will have the same level of functional capacity assessed by 6-minute walking test.
* They will be receiving the same medical treatment programme.
Exclusion Criteria:
* Other causes of anemia (e.g., hemolytic anemia, anemia of chronic disease, megaloblastic anemia, thalassemia, or sickle cell disease).
* Severe anemia (hemoglobin \< 8.0 g/dL)
* History of chronic kidney disease, liver disease, or malignancy.
* Current pregnancy or lactation, due to altered iron metabolism and hemoglobin thresholds.
* Recent blood transfusion or iron therapy (oral or intravenous) within the past 3 months.
* Use of hematopoietic agents (e.g., erythropoietin).
* Acute infection or inflammatory conditions at the time of enrollment.
* Inability or unwillingness to provide informed consent or comply with study procedures.
* Previous participation in complementary treatments/research within the last six months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.